
US pharma stocks gain up to 5% on Trump's move to slash drug prices
US pharma stocks rallied on Monday in line with broader market gains on the back of US President Donald Trump's announcement that he would sign an executive order on reducing prescription drug and pharmaceutical prices. While Pfizer and Eli Lilly were …